Key Takeaways from Analyst
The global fetal bovine serum industry is expected to experience steady growth over the forecast period driven by rising demand from biopharmaceutical companies for cell culture media. Fetal bovine serum acts as a growth supplement for cell culture and helps in maintaining optimal cell health and division.
Supply constraints stemming from limited bovine sources along with ethical concerns around animal testing could hamper the market growth to some extent. Alternatively, industry players are exploring plant-based and chemically defined serum-free cell culture media to reduce dependency on fetal bovine serum.
North America is expected to dominate the market. Asia Pacific is anticipated to be the fastest growing region attributed to increasing biologics production and growing R&D investment in vaccines and therapeutics.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients